254 related articles for article (PubMed ID: 25598226)
1. Gaining acceptance for the use of in vitro toxicity assays and QIVIVE in regulatory risk assessment.
Meek ME; Lipscomb JC
Toxicology; 2015 Jun; 332():112-23. PubMed ID: 25598226
[TBL] [Abstract][Full Text] [Related]
2. Quantitative in vitro to in vivo extrapolation (QIVIVE): An essential element for in vitro-based risk assessment.
Yoon M; Blaauboer BJ; Clewell HJ
Toxicology; 2015 Jun; 332():1-3. PubMed ID: 25680635
[No Abstract] [Full Text] [Related]
3. The long and winding road of progress in the use of in vitro data for risk assessment purposes: From "carnation test" to integrated testing strategies.
Blaauboer BJ
Toxicology; 2015 Jun; 332():4-7. PubMed ID: 24769060
[TBL] [Abstract][Full Text] [Related]
4. Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment.
Adeleye Y; Andersen M; Clewell R; Davies M; Dent M; Edwards S; Fowler P; Malcomber S; Nicol B; Scott A; Scott S; Sun B; Westmoreland C; White A; Zhang Q; Carmichael PL
Toxicology; 2015 Jun; 332():102-11. PubMed ID: 24582757
[TBL] [Abstract][Full Text] [Related]
5. Quantitative in vitro-to-in vivo extrapolation in a high-throughput environment.
Wetmore BA
Toxicology; 2015 Jun; 332():94-101. PubMed ID: 24907440
[TBL] [Abstract][Full Text] [Related]
6. Biotransformation in vitro: An essential consideration in the quantitative in vitro-to-in vivo extrapolation (QIVIVE) of toxicity data.
Wilk-Zasadna I; Bernasconi C; Pelkonen O; Coecke S
Toxicology; 2015 Jun; 332():8-19. PubMed ID: 25456264
[TBL] [Abstract][Full Text] [Related]
7. Dose metric considerations in in vitro assays to improve quantitative in vitro-in vivo dose extrapolations.
Groothuis FA; Heringa MB; Nicol B; Hermens JL; Blaauboer BJ; Kramer NI
Toxicology; 2015 Jun; 332():30-40. PubMed ID: 23978460
[TBL] [Abstract][Full Text] [Related]
8. Analytical challenges for conducting rapid metabolism characterization for QIVIVE.
Tolonen A; Pelkonen O
Toxicology; 2015 Jun; 332():20-9. PubMed ID: 23994130
[TBL] [Abstract][Full Text] [Related]
9. Quantitative in vitro to in vivo extrapolation of cell-based toxicity assay results.
Yoon M; Campbell JL; Andersen ME; Clewell HJ
Crit Rev Toxicol; 2012 Sep; 42(8):633-52. PubMed ID: 22667820
[TBL] [Abstract][Full Text] [Related]
10. A critical appraisal of the process of regulatory implementation of novel in vivo and in vitro methods for chemical hazard and risk assessment.
Piersma AH; Ezendam J; Luijten M; Muller JJ; Rorije E; van der Ven LT; van Benthem J
Crit Rev Toxicol; 2014 Nov; 44(10):876-94. PubMed ID: 25058877
[TBL] [Abstract][Full Text] [Related]
11. Toxicology in the 21st century--working our way towards a visionary reality.
Berg N; De Wever B; Fuchs HW; Gaca M; Krul C; Roggen EL
Toxicol In Vitro; 2011 Jun; 25(4):874-81. PubMed ID: 21338664
[TBL] [Abstract][Full Text] [Related]
12. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
[TBL] [Abstract][Full Text] [Related]
13. Computational systems biology and dose-response modeling in relation to new directions in toxicity testing.
Zhang Q; Bhattacharya S; Andersen ME; Conolly RB
J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):253-76. PubMed ID: 20574901
[TBL] [Abstract][Full Text] [Related]
14. Contribution of new technologies to characterization and prediction of adverse effects.
Rouquié D; Heneweer M; Botham J; Ketelslegers H; Markell L; Pfister T; Steiling W; Strauss V; Hennes C
Crit Rev Toxicol; 2015 Feb; 45(2):172-83. PubMed ID: 25615431
[TBL] [Abstract][Full Text] [Related]
15. Virtual tissues in toxicology.
Shah I; Wambaugh J
J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):314-28. PubMed ID: 20574905
[TBL] [Abstract][Full Text] [Related]
16. Prediction of in vivo developmental toxicity of all-trans-retinoic acid based on in vitro toxicity data and in silico physiologically based kinetic modeling.
Louisse J; Bosgra S; Blaauboer BJ; Rietjens IM; Verwei M
Arch Toxicol; 2015 Jul; 89(7):1135-48. PubMed ID: 24935252
[TBL] [Abstract][Full Text] [Related]
17. Pathway Based Toxicology and Fit-for-Purpose Assays.
Clewell RA; McMullen PD; Adeleye Y; Carmichael PL; Andersen ME
Adv Exp Med Biol; 2016; 856():205-230. PubMed ID: 27671724
[TBL] [Abstract][Full Text] [Related]
18. The current status of exposure-driven approaches for chemical safety assessment: A cross-sector perspective.
Sewell F; Aggarwal M; Bachler G; Broadmeadow A; Gellatly N; Moore E; Robinson S; Rooseboom M; Stevens A; Terry C; Burden N
Toxicology; 2017 Aug; 389():109-117. PubMed ID: 28774667
[TBL] [Abstract][Full Text] [Related]
19. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
[TBL] [Abstract][Full Text] [Related]
20. Implementation challenges for designing integrated in vitro testing strategies (ITS) aiming at reducing and replacing animal experimentation.
De Wever B; Fuchs HW; Gaca M; Krul C; Mikulowski S; Poth A; Roggen EL; Vilà MR
Toxicol In Vitro; 2012 Apr; 26(3):526-34. PubMed ID: 22269383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
